Board Certification and Academic Information
||Pediatrics - Professor (Clinical)
||American Board of Pediatrics (Sub: Neo-Peri)
American Board of Pediatrics (Pediatrics)
Academic Office Locations
|Academic Office Phone Number
||Academic Office Address
295 Chipeta Way
Salt Lake City, UT 84108
Dr. Faix has been an academic neonatologist for more than 30 years. He has cultivated his strong clinical and research interest in perinatal and neonatal infectious diseases throughout this time (as reflected in his CV), but has also demonstrated academic inquiry, expertise and critical though in several other areas within the realms of clinical trials and neonatal-perinatal medicine. He is currently a Professor of Pediatrics and provides numerous administrative and educational services to the University, PCMC, Intermountain Healthcare and other healthcare bodies.
Dr. Faix received his undergraduate degree from Dartmouth College and his medical degree at Cornell University Medical College. After completing his pediatric residency at the University of Michigan, he completed his training in Neonatal-Perinatal Medicine at Duke University. He returned to the University of Michigan as a faculty member in 1981 and eventually became Professor of Pediatrics with tenure and served as Director of the Division of Neonatal-Perinatal Medicine and their Fellowship training program. He came to the University of Utah in 2002 and continues to ‘learn something new every day’. He particularly enjoys teaching and has earned a number of awards for this avid interest. He opines that his greatest source for ‘learning something new every day’ are the many thoughtful students and trainees he is privileged to interact with.
Dr. Faix has had a longstanding interest in clinical aspects of neonatal, perinatal and nosocomial infectious diseases, with particular interest in those caused by Candida, cytomegalovirus, group B streptococcus and coagulase-negative staphylococcus. More recently, he was the PI for the Utah center of the NICHD Neonatal Research Network and has devoted much of his research time to implementation and design of clinical trials in high-risk newborns, addressing prevention and/or amelioration of chronic lung disease, retinopathy of prematurity, hypoxic-ischemic brain injury and necrotizing enterocolitis. He is also actively involved in development of protocols and practice for prevention of nosocomial infection in the NICU.